SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Street Poller Media and The Boom of the Street Interview Ad Industry 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Toyota Global Sales Fall as China Demand Slumps 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Add as a preferred source on Google
FRANKLIN, Tenn., April 09, 2018 -- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that it will release its first quarter 2018 earnings on Tuesday, May 1, 2018, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, May 2, 2018. Additionally, a live broadcast of the earnings conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available through May 15, 2018.
About Acadia
Acadia is a provider of behavioral healthcare services. At December 31, 2017, Acadia operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in 39 states, the United Kingdom and Puerto Rico. Acadia provides behavioral health and addiction services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.
Contact: Gretchen Hommrich Director, Investor Relations (615) 861-6000
